173 / 490
171
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
POSTERS
> The impact of dose on survival in adjuvant chemoradiation pancreatic
cancer
L. De Filippo (Italy), G.C. Mattiucci, A.G. Morganti, M. Falconi, R.G.P.M.
Van Stiphout, S. Alfieri, M. Balducci, F.A. Calvo, J.M. Herman,
G. Macchia, B.W. Maidment III, G. Mantini, R.C. Miller, W. Regine,
M. Reni, V. Valentini
PO-0707
> Advanced age is no contraindication for chemoradiotherapy with
curative intent in oesophageal cancer
F. Voncken (The Netherlands), R. Van der Kaaij, K. Sikorska,
E. Van Werkhoven, J. Van Dieren, C. Grootscholten, P. Snaebjornsson,
J. Van Sandick, B. Aleman
PO-0708
> Interobserver variation of CT and FDG-PET based GTV for
oesophageal cancer: a Dutch nationwide study
M.E. Nowee (The Netherlands), F.E. Voncken, A.N. Kotte, L. Goense,
P.S.N. Van Rossum, A.L.H.M.W. Van Lier, B.M. Aleman, M. Van Vulpen,
G.J. Meijer, I.M. Lips
PO-0709
> Large interobserver variation of delineated target volumes of pancreatic
cancer in the Netherlands
E. Versteijne (The Netherlands), O. Gurney-Champion, A. Van der Horst,
E. Lens, M. Kolff, H. Heerkens, G. Paardekooper, M. Berbee, J. Buijsen,
P. Vande Putte, K. Neelis, M. Van Herk, A. Bel, G. Van Tienhoven
PO-0710
> Relating CT image heterogeneity to patient outcome in the SCOPE 1
oesophageal cancer trial
R. Carrington (UK), E. Spezi, S. Gwynne, J. Staffurth,
T. Crosby
PO-0711
> Stereotactic body radiotherapy in the treatment of inoperable
hepatocellular carcinoma
P. Franco (Italy), A. Guarneri, E. Trino, M. Levis, F. Giglioli, A.R. Filippi,
R. Ragona, U. Ricardi
PO-0712
> Conformity analysis of target-volume definition for margin-directed
boost in pancreatic cancer SBRT
D. Holyoake (UK), M. Robinson, D. Grose, D. McIntosh,
D. Sebag-Montefiore, G. Radhakrishna, N. Patel, S. Mukherjee, M. Hawkins
PO-0713
> Proposal for the delineation of the clinical target volume in biliary tract
cancer radiotherapy
J. Socha (Poland), M. Michalak, G. Wołąkiewicz, L. Kępka
PO-0714